Eli Lilly's Retatrutide Offered to Patients Pre-FDA Approval | Retatrutide News

Eli Lilly is offering its new weight loss drug, Retatrutide, to some patients before FDA approval. This move highlights the growing significance of GLP-...
Market News · October 25, 2026